These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38917326)

  • 1. Aptamer binding footprints discriminate α-synuclein fibrillar polymorphs from different synucleinopathies.
    Bouvier-Müller A; Fourmy D; Fenyi A; Bousset L; Melki R; Ducongé F
    Nucleic Acids Res; 2024 Jun; ():. PubMed ID: 38917326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The structural differences between patient-derived α-synuclein strains dictate characteristics of Parkinson's disease, multiple system atrophy and dementia with Lewy bodies.
    Van der Perren A; Gelders G; Fenyi A; Bousset L; Brito F; Peelaerts W; Van den Haute C; Gentleman S; Melki R; Baekelandt V
    Acta Neuropathol; 2020 Jun; 139(6):977-1000. PubMed ID: 32356200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel antibodies detect additional α-synuclein pathology in synucleinopathies: potential development for immunotherapy.
    Nimmo JT; Verma A; Dodart JC; Wang CY; Savistchenko J; Melki R; Carare RO; Nicoll JAR
    Alzheimers Res Ther; 2020 Nov; 12(1):159. PubMed ID: 33256825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylated α-synuclein in skin Schwann cells: a new biomarker for multiple system atrophy.
    Donadio V; Incensi A; Rizzo G; Westermark GT; Devigili G; De Micco R; Tessitore A; Nyholm D; Parisini S; Nyman D; Tedeschi G; Eleopra R; Ingelsson M; Liguori R
    Brain; 2023 Mar; 146(3):1065-1074. PubMed ID: 35552610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of α-Synuclein Seeding-Dependent Aggregation by ssDNA Aptamers Specific to C-Terminally Truncated α-Synuclein Fibrils.
    Hmila I; Sudhakaran IP; Ghanem SS; Vaikath NN; Poggiolini I; Abdesselem H; El-Agnaf OMA
    ACS Chem Neurosci; 2022 Dec; 13(23):3330-3341. PubMed ID: 36348612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural and Functional Insights into α-Synuclein Fibril Polymorphism.
    Mehra S; Gadhe L; Bera R; Sawner AS; Maji SK
    Biomolecules; 2021 Sep; 11(10):. PubMed ID: 34680054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring α-synuclein aggregation.
    Estaun-Panzano J; Arotcarena ML; Bezard E
    Neurobiol Dis; 2023 Jan; 176():105966. PubMed ID: 36527982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oligodendrocytes Prune Axons Containing α-Synuclein Aggregates In Vivo: Lewy Neurites as Precursors of Glial Cytoplasmic Inclusions in Multiple System Atrophy?
    De Nuccio F; Kashyrina M; Serinelli F; Laferrière F; Lofrumento DD; De Giorgi F; Ichas F
    Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post mortem cerebrospinal fluid α-synuclein levels are raised in multiple system atrophy and distinguish this from the other α-synucleinopathies, Parkinson's disease and Dementia with Lewy bodies.
    Foulds PG; Yokota O; Thurston A; Davidson Y; Ahmed Z; Holton J; Thompson JC; Akiyama H; Arai T; Hasegawa M; Gerhard A; Allsop D; Mann DM
    Neurobiol Dis; 2012 Jan; 45(1):188-95. PubMed ID: 21856424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropathology and molecular diagnosis of Synucleinopathies.
    Koga S; Sekiya H; Kondru N; Ross OA; Dickson DW
    Mol Neurodegener; 2021 Dec; 16(1):83. PubMed ID: 34922583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphic Alpha-Synuclein Oligomers: Characterization and Differential Detection with Novel Corresponding Antibodies.
    Moore K; Sengupta U; Puangmalai N; Bhatt N; Kayed R
    Mol Neurobiol; 2023 May; 60(5):2691-2705. PubMed ID: 36707462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FKBP12-immunopositive inclusions in patients with α-synucleinopathies.
    Honjo Y; Ayaki T; Horibe T; Ito H; Takahashi R; Kawakami K
    Brain Res; 2018 Feb; 1680():39-45. PubMed ID: 29246765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential Membrane Binding and Seeding of Distinct α-Synuclein Fibrillar Polymorphs.
    Shrivastava AN; Bousset L; Renner M; Redeker V; Savistchenko J; Triller A; Melki R
    Biophys J; 2020 Mar; 118(6):1301-1320. PubMed ID: 32059758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond Strains: Molecular Diversity in Alpha-Synuclein at the Center of Disease Heterogeneity.
    Wojewska MJ; Otero-Jimenez M; Guijarro-Nuez J; Alegre-Abarrategui J
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathological α-synuclein detected by real-time quaking-induced conversion in synucleinopathies.
    Huang J; Yuan X; Chen L; Hu B; Wang H; Wang Y; Huang W
    Exp Gerontol; 2024 Mar; 187():112366. PubMed ID: 38280659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. α-Synuclein Seed Amplification Assays for Diagnosing Synucleinopathies: The Way Forward.
    Bellomo G; De Luca CMG; Paoletti FP; Gaetani L; Moda F; Parnetti L
    Neurology; 2022 Aug; 99(5):195-205. PubMed ID: 35914941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of an α-synuclein fibril and oligomer specific tracer for diagnosis of Parkinson's disease, dementia with Lewy bodies and multiple system atrophy.
    Sevenich M; Honold D; Willuweit A; Kutzsche J; Mohrlüder J; Willbold D
    Neurochem Int; 2022 Dec; 161():105422. PubMed ID: 36252819
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Dutta AK; Armstrong C; Luo D; Das B; Spencer B; Rissman RA
    ACS Chem Neurosci; 2023 Mar; 14(5):885-896. PubMed ID: 36749600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-synuclein fibrils amplified from multiple system atrophy and Parkinson's disease patient brain spread after intracerebral injection into mouse brain.
    Zhang S; Dauer K; Strohäker T; Tatenhorst L; Caldi Gomes L; Mayer S; Jung BC; Kim WS; Lee SJ; Becker S; Liesche-Starnecker F; Zweckstetter M; Lingor P
    Brain Pathol; 2023 Sep; 33(5):e13196. PubMed ID: 37485772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrillar form of α-synuclein-specific scFv antibody inhibits α-synuclein seeds induced aggregation and toxicity.
    Gupta V; Salim S; Hmila I; Vaikath NN; Sudhakaran IP; Ghanem SS; Majbour NK; Abdulla SA; Emara MM; Abdesselem HB; Lukacsovich T; Erskine D; El-Agnaf OMA
    Sci Rep; 2020 May; 10(1):8137. PubMed ID: 32424162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.